Can methyldopa be used in patients with peripheral vascular disease and what are the potential benefits or risks in this population?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Methyldopa can be used in patients with peripheral vascular disease, but caution is advised as it may exacerbate symptoms of Raynaud’s phenomenon.